davunetide

Known as: NAP peptide, NAPVSIPQ peptide 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2009-2017
024620092017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
BACKGROUND In preclinical studies, davunetide promoted microtubule stability and reduced tau phosphorylation. Because progressive… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • table 3
Is this relevant?
2014
2014
Genome-wide association studies have identified strong associations between the risk of developing Parkinson's disease (PD) and… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
  • figure 2
Is this relevant?
Review
2014
Review
2014
This review focuses on the therapeutic effects and mechanisms of action of NAP (davunetide), an eight amino acid snippet derived… (More)
Is this relevant?
2013
2013
Schizophrenia is associated with extensive neurocognitive and behavioral impairments. Studies indicate that N-acetylaspartate… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
Is this relevant?
2013
2013
Alzheimer’s disease (AD) is a devastating neurodegenerative disease causing irreversible cognitive decline in the elderly. There… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2013
2013
NAP (davunetide) is a novel neuroprotective compound with mechanism of action that appears to involve microtubule (MT… (More)
Is this relevant?
2012
2012
BACKGROUND Cognitive dysfunction is a key predictor of functional disability in schizophrenia. Davunetide (AL-108, NAP) is an… (More)
  • figure 1
  • figure 2
  • figure 3
  • table 2
  • table 1
Is this relevant?
2011
2011
AIMS Central nervous system complications including cognitive impairment are an early manifestation of diabetes mellitus, also… (More)
Is this relevant?
Review
2011
Review
2011
NAP (davunetide) is an eight amino acid peptide (NAPVSIPQ) that has been shown to provide potent neuroprotection, in vitro and in… (More)
Is this relevant?
2010
2010
NAP (generic name, davunetide) is an active fragment of activity-dependent neuroprotective protein (ADNP). ADNP-/- embryos… (More)
Is this relevant?